Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units
SEC Form 4 Filing
Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 71 phantom stock units through the company's Supplemental Savings Plan on July 11, 2024.
Summary
- On July 11, 2024, Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 71 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
- These units are settled in cash following the reporting person's separation from service and may be transferred into an alternative investment account at any time.
- The price of the underlying common stock was $28.66.
- Following the transaction, Bourla directly owns 669,302 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding an insider transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests. This transaction reflects participation in a company savings plan.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of transaction: Albert Bourla acquired 71 phantom stock units. |
| 07/12/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.